News 2021-05-11

New plant for Corona vaccines

io-consultants supports R-Pharm in establishing an active ingredients manufacturing site for Corona vaccines and associated Fill & Finish area at its Illertissen plant.

The pharmaceutical company R-Pharm Germany GmbH in Illertissen, Southern Bavaria, is embarking on the production of vaccines against Covid-19. Their trusted partner io-consultants GmbH & Co. KG has been supporting them in all stages of the project, from manufacturing of the active ingredient to filling of the vaccine. R-Pharm is investing more than €30 million in the Illertissen site—from the laboratory and production itself to vaccine packaging and shipping.

The filling process is now being expanded following the successfully completed proof of concept, which io-consultants carried out together with R-Pharm. 

With their vast experience in value chain planning, io-consultants is implementing the project and advising R-Pharm on everything from manufacturing and filling processes to active ingredients logistics.

Work is being carried out at full speed to ensure full vaccination against Covid-19 as quickly as possible. “We are delighted to have the experts of io-consultants at our side. Particularly with the time pressure in our project, their vast experience in biotech manufacturing and filling is invaluable,” says Annette Steiner-Kienzler, Project Manager at R-Pharm.

About R-Pharm

R-Pharm Germany GmbH, based in Illertissen, Germany, has many years of experience producing and packaging highly effective medicines and nutritional supplements in over 150 countries worldwide. Innovative technologies combined with a highly motivated and proficient team ensure reliability, high quality standards and excellent value for money. This means R‑Pharm can set the highest standards in terms of patient safety and intensive personal contact with its customers and business partners.

Your contact
Nathalie Müller
Marketing & Public Relations